{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T03:36:05Z","timestamp":1790739365920,"version":"4.1.0"},"reference-count":88,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,4,17]],"date-time":"2023-04-17T00:00:00Z","timestamp":1681689600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Psychiatry"],"abstract":"<jats:p>Substance use disorders provide challenges for development of effective medications. Use of abused substances is likely initiated, sustained and \u201cquit\u201d by complex brain and pharmacological mechanisms that have both genetic and environmental determinants. Medical utilities of prescribed stimulants and opioids provide complex challenges for prevention: how can we minimize their contribution to substance use disorders while retaining medical benefits for pain, restless leg syndrome, attention deficit hyperactivity disorder, narcolepsy and other indications. Data required to support assessments of reduced abuse liability and resulting regulatory scheduling differs from information required to support licensing of novel prophylactic or therapeutic anti-addiction medications, adding further complexity and challenges. I describe some of these challenges in the context of our current efforts to develop pentilludin as a novel anti-addiction therapeutic for a target that is strongly supported by human and mouse genetic and pharmacologic studies, the receptor type protein tyrosine phosphatase D (PTPRD).<\/jats:p>","DOI":"10.3389\/fpsyt.2023.1031283","type":"journal-article","created":{"date-parts":[[2023,4,17]],"date-time":"2023-04-17T05:30:09Z","timestamp":1681709409000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["Selecting the appropriate hurdles and endpoints for pentilludin, a novel antiaddiction pharmacotherapeutic targeting the receptor type protein tyrosine phosphatase D"],"prefix":"10.3389","volume":"14","author":[{"given":"George R.","family":"Uhl","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,4,17]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"e0206100","DOI":"10.1371\/journal.pone.0206100","article-title":"Trends in use of prescription stimulants in the United States and Territories, 2006 to 2016","volume":"13","author":"Piper","year":"2018","journal-title":"PLoS ONE."},{"key":"B2","doi-asserted-by":"publisher","first-page":"108089","DOI":"10.1016\/j.drugalcdep.2020.108089","article-title":"Trends in characteristics of individuals who use methamphetamine in the United States, 2015\u20132018","volume":"213","author":"Palamar","year":"2020","journal-title":"Drug Alcohol Depend."},{"key":"B3","doi-asserted-by":"publisher","first-page":"107592","DOI":"10.1016\/j.drugalcdep.2019.107592","article-title":"A nationally representative analysis of \u201ctwin epidemics\u201d: rising rates of methamphetamine use among persons who use opioids","volume":"204","author":"Strickland","year":"2019","journal-title":"Drug Alcohol Depend."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1080\/10826084.2016.1271432","article-title":"Heroin and methamphetamine injection: an emerging drug use pattern","volume":"52","author":"Al-Tayyib","year":"2017","journal-title":"Subst Use Misuse."},{"key":"B5","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1097\/YCO.0000000000000717","article-title":"The rise of illicit fentanyls, stimulants and the fourth wave of the opioid overdose crisis","volume":"34","author":"Ciccarone","year":"2021","journal-title":"Curr Opin Psychiatry."},{"key":"B6","doi-asserted-by":"publisher","first-page":"e2226544","DOI":"10.1001\/jamanetworkopen.2022.26544","article-title":"Association of methamphetamine and opioid use with nonfatal overdose in rural communities","volume":"5","author":"Korthuis","year":"2022","journal-title":"JAMA Netw Open."},{"key":"B7","doi-asserted-by":"publisher","first-page":"108162","DOI":"10.1016\/j.drugalcdep.2020.108162","article-title":"Substance use patterns and health profiles among US adults who use opioids, methamphetamine, or both, 2015\u20132018","volume":"214","author":"Shearer","year":"2020","journal-title":"Drug Alcohol Depend."},{"key":"B8","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1097\/MLR.0000000000001460","article-title":"Service involvement across multiple sectors among people who use opioids, methamphetamine, or both, United States-2015\u20132018","volume":"59","author":"Howell","year":"2021","journal-title":"Med Care."},{"key":"B9","year":"","journal-title":"Report of the President's Comission on Combatting Drug Addiction and the Opioid Crisis"},{"key":"B10","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1080\/00952990.2022.2065638","article-title":"Long-term patient outcomes following buprenorphine\/naloxone treatment for opioid use disorder: a retrospective analysis in a commercially insured population","volume":"48","author":"Hasan","year":"2022","journal-title":"Am J Drug Alcohol Abus."},{"key":"B11","first-page":"176","article-title":"Lapse and relapse following inpatient treatment of opiate dependence","volume":"103","author":"Smyth","year":"2010","journal-title":"Ir Med J."},{"key":"B12","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.drugalcdep.2014.02.702","article-title":"Time to relapse following treatment for methamphetamine use: a long-term perspective on patterns and predictors","volume":"139","author":"Brecht","year":"2014","journal-title":"Drug Alcohol Depend."},{"key":"B13","doi-asserted-by":"publisher","first-page":"S65","DOI":"10.1016\/j.drugalcdep.2009.08.006","article-title":"Risk management and post-marketing surveillance for the abuse of medications acting on the central nervous system: expert panel report","volume":"1","author":"Johanson","year":"2009","journal-title":"Drug Alcohol Depend."},{"key":"B14","doi-asserted-by":"publisher","first-page":"S14","DOI":"10.1016\/j.drugalcdep.2009.04.003","article-title":"Principles of laboratory assessment of drug abuse liability and implications for clinical development","volume":"1","author":"Carter","year":"2009","journal-title":"Drug Alcohol Depend."},{"key":"B15","doi-asserted-by":"publisher","first-page":"108997","DOI":"10.1016\/j.jneumeth.2020.108997","article-title":"Animal models of pain: diversity and benefits","volume":"348","author":"Abboud","year":"2021","journal-title":"J Neurosci Methods."},{"key":"B16","doi-asserted-by":"publisher","first-page":"173378","DOI":"10.1016\/j.pbb.2022.173378","article-title":"Rodent models of attention-deficit hyperactivity disorder: an updated framework for model validation and therapeutic drug discovery","volume":"216","author":"Kantak","year":"2022","journal-title":"Pharmacol Biochem Behav."},{"key":"B17","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1002\/mds.28401","article-title":"Consensus guidelines on rodent models of restless legs syndrome","volume":"36","author":"Salminen","year":"2021","journal-title":"Mov Disord."},{"key":"B18","doi-asserted-by":"publisher","first-page":"107993","DOI":"10.1016\/j.drugalcdep.2020.107993","article-title":"The state of clinical outcome assessments for cannabis use disorder clinical trials: a review and research agenda","volume":"212","author":"Loflin","year":"2020","journal-title":"Drug Alcohol Depend."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.drugalcdep.2015.11.004","article-title":"Measures of outcome for stimulant trials: ACTTION recommendations and research agenda","volume":"158","author":"Kiluk","year":"2016","journal-title":"Drug Alcohol Depend."},{"key":"B20","doi-asserted-by":"publisher","first-page":"107648","DOI":"10.1016\/j.drugalcdep.2019.107648","article-title":"Clinical validation of reduction in cocaine frequency level as an endpoint in clinical trials for cocaine use disorder","volume":"205","author":"Roos","year":"2019","journal-title":"Drug Alcohol Depend."},{"key":"B21","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1111\/add.14289","article-title":"What defines a clinically meaningful outcome in the treatment of substance use disorders: reductions in direct consequences of drug use or improvement in overall functioning?","volume":"114","author":"Kiluk","year":"2019","journal-title":"Addiction."},{"key":"B22","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.drugalcdep.2017.07.020","article-title":"Initial validation of a proxy indicator of functioning as a potential tool for establishing a clinically meaningful cocaine use outcome","volume":"179","author":"Kiluk","year":"2017","journal-title":"Drug Alcohol Depend."},{"key":"B23","unstructured":"SandbergB\n          In search of a stimulant use disorder treatment: \u201cWe've been doing it all wrong\u201d Pink Sheet"},{"key":"B24","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1016\/j.conb.2013.01.029","article-title":"The neurobiology of successful abstinence","volume":"23","author":"Garavan","year":"2013","journal-title":"Curr Opin Neurobiol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1124\/pharmrev.120.000191","article-title":"Animal models of drug relapse and craving after voluntary abstinence: a review","volume":"73","author":"Fredriksson","year":"","journal-title":"Pharmacol Rev."},{"key":"B26","doi-asserted-by":"publisher","first-page":"a040287","DOI":"10.1101\/cshperspect.a040287","article-title":"Animal models of the behavioral symptoms of substance use disorders","volume":"1","author":"Vanderschuren","year":"2021","journal-title":"Cold Spring Harb Perspect Med."},{"key":"B27","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1038\/s41386-018-0234-2","article-title":"Relapse to opioid seeking in rat models: behavior, pharmacology and circuits","volume":"44","author":"Reiner","year":"2019","journal-title":"Neuropsychopharmacology."},{"key":"B28","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.pnpbp.2018.01.002","article-title":"Modeling cocaine relapse in rodents: behavioral considerations and circuit mechanisms","volume":"87","author":"Farrell","year":"2018","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry."},{"key":"B29","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1038\/npp.2013.240","article-title":"Cell adhesion molecules: druggable targets for modulating the connectome and brain disorders?","volume":"39","author":"Uhl","year":"2014","journal-title":"Neuropsychopharmacology."},{"key":"B30","doi-asserted-by":"publisher","first-page":"11864","DOI":"10.1073\/pnas.0500329102","article-title":"Pooled association genome scanning: validation and use to identify addiction vulnerability loci in two samples","volume":"102","author":"Lima","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"B31","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1002\/ajmg.b.30436","article-title":"Addiction molecular genetics: 639, 401 SNP whole genome association identifies many \u201ccell adhesion\u201d genes","volume":"14","author":"Liu","year":"2006","journal-title":"Am J Med Genet B Neuropsychiatr Genet."},{"key":"B32","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1002\/ajmg.b.31143","article-title":"\u201cReplicated\u201d genome wide association for dependence on illegal substances: genomic regions identified by overlapping clusters of nominally positive SNPs","volume":"156","author":"Drgon","year":"2011","journal-title":"Am J Med Genet B Neuropsychiatr Genet."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1038\/npp.2014.290","article-title":"Genome-wide association study of copy number variations (CNVs) with opioid dependence","volume":"40","author":"Li","year":"2015","journal-title":"Neuropsychopharmacology."},{"key":"B34","article-title":"J, Grant BF, Chou P","author":"Jung","year":"","journal-title":"Identification of novel genetic variants of DMS5 alcohol use disorder: genome wide association study in National Epidemiological Survey on Alcohol Related Conditions-III Abstracts, World Congress of Psychaitroc Genetics."},{"key":"B35","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/1471-2156-8-10","article-title":"Molecular genetics of nicotine dependence and abstinence: whole genome association using 520,000 SNPs","volume":"8","author":"Uhl","year":"2007","journal-title":"BMC Genet."},{"key":"B36","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1001\/archpsyc.65.6.683","article-title":"Molecular genetics of successful smoking cessation: convergent genome-wide association study results","volume":"65","author":"Uhl","year":"2008","journal-title":"Arch Gen Psychiatry."},{"key":"B37","doi-asserted-by":"publisher","first-page":"180","DOI":"10.3390\/jcm9010180","article-title":"Genome-wide association study of opioid cessation","volume":"9","author":"Cox","year":"2020","journal-title":"J Clin Med."},{"key":"B38","doi-asserted-by":"publisher","first-page":"2132","DOI":"10.1038\/s41386-021-01097-0","article-title":"Genetic contributions to alcohol use disorder treatment outcomes: a genome-wide pharmacogenomics study","volume":"46","author":"Biernacka","year":"2021","journal-title":"Neuropsychopharmacology."},{"key":"B39","doi-asserted-by":"publisher","first-page":"e42646","DOI":"10.1371\/journal.pone.0042646","article-title":"Genome-wide association study of d-amphetamine response in healthy volunteers identifies putative associations, including cadherin 13 (CDH13)","volume":"7","author":"Hart","year":"2012","journal-title":"PLoS ONE."},{"key":"B40","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1016\/j.tcb.2013.07.004","article-title":"LAR-RPTPs: synaptic adhesion molecules that shape synapse development","volume":"23","author":"Um","year":"2013","journal-title":"Trends Cell Biol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1016\/j.tins.2013.06.002","article-title":"Protein tyrosine phosphatases PTPdelta, PTPsigma, and LAR: presynaptic hubs for synapse organization","volume":"36","author":"Takahashi","year":"2013","journal-title":"Trends Neurosci."},{"key":"B42","doi-asserted-by":"publisher","first-page":"e14530","DOI":"10.7554\/eLife.14530","article-title":"Analysis of protein phosphorylation in nerve terminal reveals extensive changes in active zone proteins upon exocytosis","volume":"5","author":"Kohansal-Nodehi","year":"2016","journal-title":"Elife."},{"key":"B43","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/0014-5793(94)01188-5","article-title":"Developmental regulation of gene expression for the MPTP delta isoforms in the central nervous system and the immune system","volume":"355","author":"Mizuno","year":"1994","journal-title":"FEBS Lett."},{"key":"B44","doi-asserted-by":"publisher","first-page":"e104150","DOI":"10.15252\/embj.2019104150","article-title":"Splice-dependent trans-synaptic PTPdelta-IL1RAPL1 interaction regulates synapse formation and non-REM sleep","volume":"39","author":"Park","year":"2020","journal-title":"EMBO J."},{"key":"B45","doi-asserted-by":"publisher","first-page":"9686","DOI":"10.1038\/srep09686","article-title":"Structure of Slitrk2-PTPdelta complex reveals mechanisms for splicing-dependent trans-synaptic adhesion","volume":"5","author":"Yamagata","year":"2015","journal-title":"Sci Rep."},{"key":"B46","doi-asserted-by":"publisher","first-page":"2588","DOI":"10.1523\/JNEUROSCI.4637-11.2012","article-title":"Interleukin-1 receptor accessory protein organizes neuronal synaptogenesis as a cell adhesion molecule","volume":"32","author":"Yoshida","year":"2012","journal-title":"J Neurosci."},{"key":"B47","doi-asserted-by":"publisher","first-page":"13966","DOI":"10.1074\/jbc.M109.061127","article-title":"Trans-synaptic adhesions between netrin-G ligand-3 (NGL-3) and receptor tyrosine phosphatases LAR, protein-tyrosine phosphatase delta (PTPdelta), and PTPsigma via specific domains regulate excitatory synapse formation","volume":"285","author":"Kwon","year":"2010","journal-title":"J Biol Chem."},{"key":"B48","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1038\/s41467-017-02414-2","article-title":"Structural basis of SALM5-induced PTPdelta dimerization for synaptic differentiation","volume":"9","author":"Lin","year":"2018","journal-title":"Nat Commun."},{"key":"B49","doi-asserted-by":"publisher","first-page":"26676","DOI":"10.1038\/srep26676","article-title":"SALM5 trans-synaptically interacts with LAR-RPTPs in a splicing-dependent manner to regulate synapse development","volume":"6","author":"Choi","year":"2016","journal-title":"Sci Rep."},{"key":"B50","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/j.cmet.2022.02.012","article-title":"Protein tyrosine phosphatase receptor delta serves as the orexigenic asprosin receptor","volume":"34","author":"Mishra","year":"2022","journal-title":"Cell Metab."},{"key":"B51","doi-asserted-by":"publisher","first-page":"115109","DOI":"10.1016\/j.bcp.2022.115109","article-title":"Substrate-selective positive allosteric modulation of PTPRD's phosphatase by flavonols","volume":"202","author":"Henderson","year":"2022","journal-title":"Biochem Pharmacol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1006\/mcne.1999.0789","article-title":"Receptor tyrosine phosphatase-delta is a homophilic, neurite-promoting cell adhesion molecular for CNS neurons","volume":"14","author":"Wang","year":"1999","journal-title":"Mol Cell Neurosci."},{"key":"B53","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1111\/nyas.14002","article-title":"PTPRD neurobiology, genetics, and initial pharmacology of a pleiotropic contributor to brain phenotypes","volume":"1451","author":"Uhl","year":"2019","journal-title":"Ann N Y Acad Sci."},{"key":"B54","doi-asserted-by":"publisher","first-page":"717","DOI":"10.2119\/molmed.2015.00017","article-title":"Mouse model for PTPRD associations with WED\/RLS and addiction: reduced expression alters locomotion, sleep behaviors and cocaine-conditioned place preference","volume":"21","author":"Drgonova","year":"2015","journal-title":"Mol Med."},{"key":"B55","doi-asserted-by":"publisher","first-page":"11597","DOI":"10.1073\/pnas.1720446115","article-title":"Cocaine reward is reduced by decreased expression of receptor-type protein tyrosine phosphatase D (PTPRD) and by a novel PTPRD antagonist","volume":"115","author":"Uhl","year":"2018","journal-title":"Proc Natl Acad Sci USA."},{"key":"B56","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1016\/j.tips.2017.03.004","article-title":"Targeting tyrosine phosphatases: time to end the stigma","volume":"38","author":"Stanford","year":"2017","journal-title":"Trends Pharmacol Sci."},{"key":"B57","doi-asserted-by":"publisher","first-page":"114868","DOI":"10.1016\/j.bcp.2021.114868","article-title":"Structure-activity studies of PTPRD phosphatase inhibitors identify a 7-cyclopentymethoxy illudalic acid analog candidate for development","volume":"195","author":"Henderson","year":"2022","journal-title":"Biochem Pharmacol."},{"key":"B58","doi-asserted-by":"publisher","first-page":"21","DOI":"10.2119\/molmed.2008.00096","article-title":"Genome-wide association for nicotine dependence and smoking cessation success in NIH research volunteers","volume":"15","author":"Drgon","year":"2009","journal-title":"Mol Med."},{"key":"B59","doi-asserted-by":"publisher","first-page":"513","DOI":"10.2119\/molmed.2010.00052","article-title":"Genome-wide association for smoking cessation success in a trial of precessation nicotine replacement","volume":"16","author":"Uhl","year":"2010","journal-title":"Mol Med."},{"key":"B60","doi-asserted-by":"publisher","first-page":"357","DOI":"10.2217\/pgs.09.156","article-title":"Genome-wide association for smoking cessation success: participants in the Patch in Practice trial of nicotine replacement","volume":"11","author":"Uhl","year":"2010","journal-title":"Pharmacogenomics."},{"key":"B61","doi-asserted-by":"publisher","first-page":"2360","DOI":"10.1111\/add.15453","article-title":"Reward drinking and naltrexone treatment response among young adult heavy drinkers","volume":"116","author":"Roos","year":"2021","journal-title":"Addiction."},{"key":"B62","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1001\/archpsyc.65.3.345","article-title":"Genome-wide association for methamphetamine dependence: convergent results from 2 samples","volume":"65","author":"Uhl","year":"2008","journal-title":"Arch Gen Psychiatry."},{"key":"B63","doi-asserted-by":"publisher","first-page":"e19210","DOI":"10.1371\/journal.pone.0019210","article-title":"Genomic regions identified by overlapping clusters of nominally-positive SNPs from genome-wide studies of alcohol and illegal substance dependence","volume":"6","author":"Johnson","year":"2011","journal-title":"PLoS One."},{"key":"B64","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1038\/mp.2012.155","article-title":"Smoking quit success genotype score predicts quit success and distinct patterns of developmental involvement with common addictive substances","volume":"19","author":"Uhl","year":"2014","journal-title":"Mol Psychiatry."},{"key":"B65","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1186\/1471-2350-9-113","article-title":"Genome wide association for substance dependence: convergent results from epidemiologic and research volunteer samples","volume":"9","author":"Johnson","year":"2008","journal-title":"BMC Med Genet."},{"key":"B66","doi-asserted-by":"publisher","first-page":"3101","DOI":"10.1038\/s41388-021-01768-8","article-title":"Protein tyrosine phosphatase receptor type D gene promotes radiosensitivity via STAT3 dephosphorylation in nasopharyngeal carcinoma","volume":"40","author":"Lin","year":"2021","journal-title":"Oncogene."},{"key":"B67","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1093\/hmg\/ddt519","article-title":"Genome-wide association study identifies multiple loci associated with bladder cancer risk","volume":"23","author":"Figueroa","year":"2014","journal-title":"Hum Mol Genet."},{"key":"B68","doi-asserted-by":"crossref","first-page":"4198","DOI":"10.1038\/s41467-021-24327-x","article-title":"Cross-ancestry GWAS meta-analysis identifies six breast cancer loci in African and European ancestry women","volume":"12","author":"Adedokun","year":"2021","journal-title":"Nat Commun."},{"key":"B69","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1002\/ijc.31076","article-title":"Genome-wide association study and meta-analysis in Northern European populations replicate multiple colorectal cancer risk loci","volume":"142","author":"Tanskanen","year":"2018","journal-title":"Int J Cancer."},{"key":"B70","doi-asserted-by":"crossref","first-page":"3166","DOI":"10.1038\/s41467-018-05427-7","article-title":"Identification of nine new susceptibility loci for endometrial cancer","volume":"9","author":"O'Mara","year":"2018","journal-title":"Nat Commun."},{"key":"B71","doi-asserted-by":"crossref","first-page":"15724","DOI":"10.1038\/ncomms15724","article-title":"Genome-wide association study identifies multiple risk loci for renal cell carcinoma","volume":"8","author":"Scelo","year":"2017","journal-title":"Nat Commun."},{"key":"B72","doi-asserted-by":"publisher","first-page":"6233","DOI":"10.1038\/s41467-020-20822-9","article-title":"Genome-wide association study identifies susceptibility loci for acute myeloid leukemia","volume":"12","author":"Lin","year":"2021","journal-title":"Nat Commun."},{"key":"B73","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1002\/jgh3.12682","article-title":"Genetic susceptibility to hepatocellular carcinoma in chromosome 22q13.31. findings of a genome-wide association study","volume":"5","author":"Wang","year":"2021","journal-title":"JGH Open."},{"key":"B74","doi-asserted-by":"publisher","first-page":"e1009254","DOI":"10.1371\/journal.pgen.1009254","article-title":"Genome-wide association meta-analysis identifies pleiotropic risk loci for aerodigestive squamous cell cancers","volume":"17","author":"Lesseur","year":"2021","journal-title":"PLoS Genet."},{"key":"B75","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1016\/j.jid.2021.08.449","article-title":"Multi-trait genetic analysis identifies autoimmune loci associated with cutaneous melanoma","volume":"142","author":"Liyanage","year":"2021","journal-title":"J Invest Dermatol."},{"key":"B76","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1038\/ng.3105","article-title":"Genome-wide association study identifies multiple susceptibility loci for diffuse large B cell lymphoma","volume":"46","author":"Cerhan","year":"2014","journal-title":"Nat Genet."},{"key":"B77","doi-asserted-by":"crossref","first-page":"3175","DOI":"10.1038\/s41467-020-16711-w","article-title":"Genome-wide association meta-analysis identifies GP2 gene risk variants for pancreatic cancer","volume":"11","author":"Lin","year":"2020","journal-title":"Nat Commun."},{"key":"B78","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/s41588-020-00748-0","article-title":"Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction","volume":"53","author":"Conti","year":"2021","journal-title":"Nat Genet."},{"key":"B79","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1158\/1055-9965.EPI-15-0652","article-title":"A comprehensive meta-analysis of case-control association studies to evaluate polymorphisms associated with the risk of differentiated thyroid carcinoma","volume":"25","author":"Figlioli","year":"2016","journal-title":"Cancer Epidemiol Biomarkers Prev."},{"key":"B80","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/S0196-0644(05)81617-8","article-title":"Jack o'lantern mushroom poisoning","volume":"20","author":"Vanden Hoek","year":"1991","journal-title":"Ann Emerg Med."},{"key":"B81","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1580\/1080-6032(","article-title":"Personal experience with jack o'lantern mushroom toxicity","volume":"13","author":"Masters","year":"2002","journal-title":"Wilderness Environ Med."},{"key":"B82","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1021\/jo00838a058","article-title":"Metabolites of clitocybe illudens. IV Illudalic acid, a sesquiterpenoid, and illudinine, a sesquiterpenoid alkaloid","volume":"34","author":"Nair","year":"1969","journal-title":"J Org Chem."},{"key":"B83","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1080\/00275514.1913.12018521","article-title":"Toxicologic studies of the mushrooms clitocybe illudens and inocybe infida","volume":"5","author":"Clark","year":"1913","journal-title":"Mycologia."},{"key":"B84","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1053\/j.gastro.2020.09.032","article-title":"Combinatorial transcriptional profiling of mouse and human enteric neurons identifies shared and disparate subtypes in situ","volume":"160","author":"May-Zhang","year":"2021","journal-title":"Gastroenterology"},{"key":"B85","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1093\/jat\/28.7.563","article-title":"Amphetamine excretion profile following multidose administration of mixed salt amphetamine preparation","volume":"28","author":"Cody","year":"2004","journal-title":"J Anal Toxicol."},{"key":"B86","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1038\/sj.npp.1301481","article-title":"Bupropion for the treatment of methamphetamine dependence","volume":"33","author":"Elkashef","year":"2008","journal-title":"Neuropsychopharmacology."},{"key":"B87","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1037\/ccp0000605","article-title":"Lower self-efficacy and greater depressive symptoms predict greater failure to recover from a single lapse cigarette","volume":"88","author":"Muench","year":"2020","journal-title":"J Consult Clin Psychol."},{"key":"B88","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1038\/npp.2017.282","article-title":"Precision medicine in alcohol dependence: a controlled trial testing pharmacotherapy response among reward and relief drinking phenotypes","volume":"43","author":"Mann","year":"2018","journal-title":"Neuropsychopharmacology."}],"container-title":["Frontiers in Psychiatry"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyt.2023.1031283\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,17]],"date-time":"2023-04-17T05:30:15Z","timestamp":1681709415000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyt.2023.1031283\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,17]]},"references-count":88,"alternative-id":["10.3389\/fpsyt.2023.1031283"],"URL":"https:\/\/doi.org\/10.3389\/fpsyt.2023.1031283","relation":{},"ISSN":["1664-0640"],"issn-type":[{"value":"1664-0640","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,17]]},"article-number":"1031283"}}